Amer Zeidan/LinkedIn
Sep 6, 2026, 10:51
Amer Zeidan: Looking Ahead to ESH MDS 2026 in Ireland
Amer Zeidan, Chief of Division of Hematologic Malignancies at Yale Comprehensive Cancer Center, Professor of Medicine, Medical Oncology and Hematology at Yale University, shared a post on LinkedIn:
“Looking forward to this excellent meeting on MDS by the European School of Haematology ESH MDS 2026 in Ireland and hope to meet many of you there…”
Stay updated with Hemostasis Today.
-
Sep 6, 2026, 10:52Panagiotis Christoforou: Six Years of Service, Growth and Global Connection with WFH
-
Sep 6, 2026, 10:50David Smadja: Unveiling the Endothelium’s Role in Thrombosis at ISTH 2026
-
Sep 6, 2026, 10:48Tareq Abadl: When and Why Do We Perform Weak D Testing?
-
Sep 6, 2026, 10:19Faezeh Kheyri: Exploring the Future of Immunohematology with Artificial Intelligence
-
Sep 6, 2026, 05:58Mohamed F Doheim: ‘Stroke as a Symphony’ – Rethinking Decision-Making in Acute Ischemic Stroke
-
Sep 6, 2026, 05:26Yousef Hindi: Unprovoked Left Renal Vein Thrombosis and Severe IDA – Long-Term Resolution and Dual-Energy CT Findings
-
Sep 6, 2026, 05:18Robert Brown: Standardizing Amniotic Fluid Embolism Diagnosis – SMFM and AFE Foundation Criteria
-
Sep 6, 2026, 04:45Mohammed Al Kanan: Early Identification of VTE Risk in Lung Cancer Patients
-
Sep 6, 2026, 04:38M. Ibrahim Siddique: Does Routine Triple Therapy Pay Off After Anterior STEMI?